JP2024538615A5 - - Google Patents

Info

Publication number
JP2024538615A5
JP2024538615A5 JP2024519447A JP2024519447A JP2024538615A5 JP 2024538615 A5 JP2024538615 A5 JP 2024538615A5 JP 2024519447 A JP2024519447 A JP 2024519447A JP 2024519447 A JP2024519447 A JP 2024519447A JP 2024538615 A5 JP2024538615 A5 JP 2024538615A5
Authority
JP
Japan
Prior art keywords
composition
conjugate
tau
administration
weeks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024519447A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538615A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077279 external-priority patent/WO2023056369A1/en
Publication of JP2024538615A publication Critical patent/JP2024538615A/ja
Publication of JP2024538615A5 publication Critical patent/JP2024538615A5/ja
Pending legal-status Critical Current

Links

JP2024519447A 2021-09-29 2022-09-29 タウホスホペプチドコンジュゲートの安全な投与の方法 Pending JP2024538615A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163261793P 2021-09-29 2021-09-29
US63/261,793 2021-09-29
PCT/US2022/077279 WO2023056369A1 (en) 2021-09-29 2022-09-29 Method of safe administration of tau phosphopeptide conjugate

Publications (2)

Publication Number Publication Date
JP2024538615A JP2024538615A (ja) 2024-10-23
JP2024538615A5 true JP2024538615A5 (cg-RX-API-DMAC7.html) 2025-10-09

Family

ID=85783654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024519447A Pending JP2024538615A (ja) 2021-09-29 2022-09-29 タウホスホペプチドコンジュゲートの安全な投与の方法

Country Status (9)

Country Link
US (1) US20250049900A1 (cg-RX-API-DMAC7.html)
EP (1) EP4408864A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024538615A (cg-RX-API-DMAC7.html)
KR (1) KR20240082368A (cg-RX-API-DMAC7.html)
CN (1) CN118613496A (cg-RX-API-DMAC7.html)
AU (1) AU2022356435A1 (cg-RX-API-DMAC7.html)
CA (1) CA3233247A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024003775A (cg-RX-API-DMAC7.html)
WO (1) WO2023056369A1 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102596236B (zh) * 2009-07-30 2015-06-24 辉瑞疫苗有限责任公司 抗原性Tau肽及其用途
TW202333768A (zh) * 2017-10-25 2023-09-01 美商健生醫藥公司 Tau胜肽之組成物及其用途
MX2021012994A (es) * 2019-04-24 2022-03-04 Janssen Pharmaceuticals Inc Administracion heterologa de vacunas tau.

Similar Documents

Publication Publication Date Title
US20200140488A1 (en) Alzheimer's disease treatment method
TWI379839B (en) Aβ immunogenic peptide carrier conjugates and methods of producing same
CN102596236B (zh) 抗原性Tau肽及其用途
CN101384279B (zh) 抗淀粉样蛋白免疫原性组合物、方法和用途
US20070134762A1 (en) Immunogenic peptide carrier conjugates and methods of producing same
AU2009257170A1 (en) Compounds for treating symptoms associated with Parkinson's disease
RU2007145052A (ru) Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера
US20100028353A1 (en) Anti-amyloid immunogenic compositions, methods and uses
HUE027563T2 (en) Use of mimotopes of alpha-synuclein epitopes in the treatment of Lewy body diseases
JP2023541669A5 (cg-RX-API-DMAC7.html)
JP2022529529A5 (cg-RX-API-DMAC7.html)
TW202212348A (zh) 用於治療阿茲海默症之β類澱粉蛋白疫苗
EP2659906A1 (en) Compositions
CN117751132A (zh) 用于治疗阿尔兹海默氏病的tau疫苗
EP2659908A1 (en) Compositions
CN121001737A (zh) Tau和β淀粉样肽免疫原组合物及相关方法
EP0597838A1 (en) Vaccine compositions
JP2024532787A5 (cg-RX-API-DMAC7.html)
CN119894531A (zh) Tau肽免疫原构建体
CN121646476A (zh) 用于治疗淀粉样变性的疫苗
JP2023508777A (ja) インターロイキン-6に対して指向される免疫応答を誘導するための免疫原性複合体
WO2006097416A1 (en) Compounds for use in the prevention and treatment of alzheimer's disease
AU2011226926A1 (en) Alzheimer's disease treatment method